EPISODE · Mar 27, 2026 · 8 MIN
#114 $CORT FDA Shock The Approval That Never Came
from SueWallSt · host SueWallSt
Dive into the Corcept Therapeutics $CORT controversy as we break down a securities class action tied to biotech approvals, FDA setbacks, and alleged misleading statements حول relacorilant. This episode is for investors, traders, and anyone following biotech stocks, clinical trials, and market volatility. Expect deep dives, case analysis, and insights into FDA risk, insider selling, and stock crashes. Visit ZLK.com for more info. Add our WhatsApp Channel We’re not lawyers or accountants, so don’t take this as legal or financial advice.
What this episode covers
Dive into the Corcept Therapeutics $CORT controversy as we break down a securities class action tied to biotech approvals, FDA setbacks, and alleged misleading statements حول relacorilant. This episode is for investors, traders, and anyone following biotech stocks, clinical trials, and market volatility. Expect deep dives, case analysis, and insights into FDA risk, insider selling, and stock crashes. Visit ZLK.com for more info. Add our WhatsApp Channel We’re not lawyers or accountants, so don’t take this as legal or financial advice.
NOW PLAYING
#114 $CORT FDA Shock The Approval That Never Came
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.